Klobučar, I.; Degoricija, V.; Potočnjak, I.; Trbušić, M.; Pregartner, G.; Berghold, A.; Fritz-Petrin, E.; Habisch, H.; Madl, T.; Frank, S.
HDL-apoA-II Is Strongly Associated with 1-Year Mortality in Acute Heart Failure Patients. Biomedicines 2022, 10, 1668.
https://doi.org/10.3390/biomedicines10071668
AMA Style
Klobučar I, Degoricija V, Potočnjak I, Trbušić M, Pregartner G, Berghold A, Fritz-Petrin E, Habisch H, Madl T, Frank S.
HDL-apoA-II Is Strongly Associated with 1-Year Mortality in Acute Heart Failure Patients. Biomedicines. 2022; 10(7):1668.
https://doi.org/10.3390/biomedicines10071668
Chicago/Turabian Style
Klobučar, Iva, Vesna Degoricija, Ines Potočnjak, Matias Trbušić, Gudrun Pregartner, Andrea Berghold, Eva Fritz-Petrin, Hansjörg Habisch, Tobias Madl, and Saša Frank.
2022. "HDL-apoA-II Is Strongly Associated with 1-Year Mortality in Acute Heart Failure Patients" Biomedicines 10, no. 7: 1668.
https://doi.org/10.3390/biomedicines10071668
APA Style
Klobučar, I., Degoricija, V., Potočnjak, I., Trbušić, M., Pregartner, G., Berghold, A., Fritz-Petrin, E., Habisch, H., Madl, T., & Frank, S.
(2022). HDL-apoA-II Is Strongly Associated with 1-Year Mortality in Acute Heart Failure Patients. Biomedicines, 10(7), 1668.
https://doi.org/10.3390/biomedicines10071668